Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

M&A health care deals slow on debt fears

After a heady 2021, activity in European health care M&A is slowing down. Big ticket auctions have been withdrawn and processes are often run more cautiously as dual track, rather than general auctions. But underlying demand for health care assets is strong, with PE sitting on trillions of recently raised dry powder. Listed groups look cheap. HBI catches up with bankers from across Europe for their take.
October 14, 2022

Henry Dunant-Euromedica merger unlikely to sell for three years

The company formed as a result of the merger between Euromedica and Imithea, the parent company of Henry Dunant, Greece’s largest private hospital, is unlikely to sell for three years, HBI hears. Click here to read our reports on the for-profit hospital sector, and here to read more about Euromedica, and here to read more […]
October 14, 2022

CVC to buy back Quironsalud?

Rumours circulate that Quironsalud, the Spanish hospital subsidiary of hospital chain Fresenius Helios, may be sold to private equity firm CVC or KKR, HBI hears. But others say the new CEO of Helios' parent, Fresenius SE, is unlikely to go for the strategy and suggest the dialysis arm could be put on the block instead.
October 14, 2022

Burjeel sets price for “29x over-subscribed” IPO

Major UAE hospital group Burjeel Holdings has chosen to set its IPO price at just 2 dirhams ($0.54) per share. It plans to sell 11% of its share capital (550.7 million shares) when it goes public on Monday, October 10, which will raise 1.1bn dirhams ($299.51m) at this price.
October 7, 2022

Indian M&A roundup

Indian health care is seeing a flurry of activity. Evercare-owned Care Hospitals is reportedly up for sale in India, while IHH Healthcare Bhd has expressed renewed interest in India after the Indian Supreme Court passed judgement in relation to its contentious dealings with Fortis. Meantime, the largest shareholder in India's second largest eye hospital has sold its stake.
September 30, 2022

Is the PE tap being turned off?

Economic uncertainty could well mean a slowdown in M&A from private equity houses. Could we be facing a repeat of the dark days of 2009, and a halving of deal flow, or is there light on the horizon? HBI has been chatting with consultants and advisers over the last couple of weeks to see if there is a consensus.
September 23, 2022

Is Bridgepoint looking to sell Diaverum in Q4?

Swedish pan-European dialysis group Diaverum could be up for sale in Q4. Reports suggest PE owner Bridgepoint has reportedly appointed American investment bank Citi to review strategic options for a sale.
September 23, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us